Showing results (31-40 of 756) with videos related to

Sort By:
Pageof 76
The Lancet. Gastroenterology & Hepatology|September 22, 2018
Home-based versus office-based biofeedback therapy for constipation with dyssynergic defecation: a randomised controlled trialSatish S C Rao, Jessica A Valestin, Xuelian Xiang, et al.
The Lancet. Gastroenterology & Hepatology|October 9, 2021
Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trialRui-Hua Xu, Yanqiao Zhang, Hongming Pan, et al.
The Lancet. Gastroenterology & Hepatology|October 9, 2021
Liver transplantation for alcohol-related liver disease in the UK: revised UK Liver Advisory Group recommendations for referralSteven Masson, Helen Aldersley, Joanna A Leithead, et al.
The Lancet. Gastroenterology & Hepatology|September 23, 2021
Fully automated magnetically controlled capsule endoscopy for examination of the stomach and small bowel: a prospective, feasibility, two-centre studyYu-Feng Xiao, Zhi-Xuan Wu, Song He, et al.
The Lancet. Gastroenterology & Hepatology|June 15, 2019
Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based studyEline H Schreuders, Esmée J Grobbee, Stella A V Nieuwenburg, et al.
The Lancet. Gastroenterology & Hepatology|April 10, 2022
Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
The Lancet. Gastroenterology & Hepatology|April 9, 2022
The role of mucins in gastrointestinal barrier function during health and diseaseTom Breugelmans, Baptiste Oosterlinck, Wout Arras, et al.
The Lancet. Gastroenterology & Hepatology|March 18, 2022
Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysisEvan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
The Lancet. Gastroenterology & Hepatology|June 27, 2017
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trialTim Meyer, Richard Fox, Yuk Ting Ma, et al.
The Lancet. Gastroenterology & Hepatology|June 4, 2017
Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4-5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trialAnnette Bruchfeld, David Roth, Paul Martin, et al.
Pageof 76